These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33459189)

  • 1. Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we? - results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United Kingdom.
    Joshi H; Sali G; Paramore L; Jones R; Lazarowicz H; Kujawa ML; Pandit A; David R; Wilson K; Bates C; Shergill I; Gan C; El-Husseiny T; Mukhtar B; Appanna T; Veeratterapillay R; Harding C; Crockett M; Dawson C; Simpson R; Zelhof B; Starmer B; Mukherjee R; Bourdoumis A; Jelski J; Hashim H; McCabe J; Shaw G; Chow K; Betts C
    Scott Med J; 2021 May; 66(2):58-65. PubMed ID: 33459189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.
    Presicce F; De Nunzio C; Tubaro A
    Curr Urol Rep; 2018 Jul; 19(9):70. PubMed ID: 29987480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phamacological treatment of persistant lower urinary tract symptoms after a transurethral resection of the prostate is predictive of a new surgical treatment: 10 years follow-up study.
    De Nunzio C; Franco A; Lombardo R; Baldassarri V; Borghesi A; Li Marzi V; Trucchi A; Agrò EF; Tubaro A;
    Neurourol Urodyn; 2021 Feb; 40(2):722-727. PubMed ID: 33508153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).
    Magistro G; Stief CG; Gratzke C
    Curr Urol Rep; 2017 Aug; 18(10):82. PubMed ID: 28852996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining and discriminating responders from non-responders following transurethral resection of the prostate.
    Sagen E; Hedelin H; Nelzén O; Peeker R
    Scand J Urol; 2018; 52(5-6):437-444. PubMed ID: 30681023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
    Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
    Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of causes of failure of medical treatment in patients undergoing surgery for benign prostate enlargement.
    Anand A; Gupta NP; Dogra PN; Seth A
    Urologia; 2022 Nov; 89(4):553-558. PubMed ID: 34965812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.
    Krambeck AE; Jacobson DJ; McGree ME; Lightner DJ; Lieber MM; Jacobsen SJ; St Sauver JL
    BJU Int; 2012 Nov; 110(9):1332-7. PubMed ID: 22471348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis.
    Creta M; Manfredi C; Arcaniolo D; Spirito L; Kaplan SA; Woo HH; De Nunzio C; Gilling P; Bach T; De Sio M; Imbimbo C; Mirone V; Longo N; Fusco F
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):367-384. PubMed ID: 37244971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.
    Mayer EK; Kroeze SG; Chopra S; Bottle A; Patel A
    BJU Int; 2012 Dec; 110(11):1595-601. PubMed ID: 22540956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging, newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy.
    Pham H; Sharma P
    Can J Urol; 2018 Apr; 25(2):9228-9237. PubMed ID: 29679999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Three horse shoe-like incision" holmium laser enucleation of the prostate: first experience with a novel en bloc technique for anatomic transurethral prostatectomy.
    Miernik A; Schoeb DS
    World J Urol; 2019 Mar; 37(3):523-528. PubMed ID: 30039386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
    Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
    Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption, Safety, and Retreatment Rates of Prostatic Urethral Lift for Benign Prostatic Enlargement.
    Gaffney CD; Basourakos SP; Al Hussein Al Awamlh B; Wu X; Cai PY; Hijaz A; Jaeger I; Lee RK; Shoag JE
    J Urol; 2021 Aug; 206(2):409-415. PubMed ID: 33793296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study.
    Bhatt NR; Davis NF; Witjes WP; Bjartell A; Caris C; Patel A; de la Taille A; Tubaro A
    World J Urol; 2021 Feb; 39(2):517-526. PubMed ID: 32367157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.